Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: CDC polio vaccine policy

Executive Summary

CDC polio vaccine policy: Centers for Disease Control & Prevention will change its polio vaccination policy to "include a greatly enhanced role for inactivated polio vaccine," CDC's Advisory Committee on Immunization Practices reports. The change is aimed at reducing the incidence of vaccine-associated paralytic polio, which is caused by oral live vaccine in roughly eight to 10 children per year. The new vaccination standard could be either an IPV-only regimen or some form of sequential or combination regimen including both IPV and oral live vaccine ("The Pink Sheet" June 26, T&G-7)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel